Similar articles

• [The immunological basis of the administration of DTP-polio vaccine].

  Cohen H. Cohen H. Verh K Acad Geneeskd Belg. 2000;62(4):245-67. Verh K Acad Geneeskd Belg. 2000. PMID: 11004905 Review. Dutch.
• Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.

  Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM. Grimprel E, et al. Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013. Vaccine. 2005. PMID: 15882526 Clinical Trial.
• Vaccines and immunization schedules.

  Nagel J. Nagel J. Trop Geogr Med. 1985 Sep;37(3):S42-9. Trop Geogr Med. 1985. PMID: 2866613
• The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.

  Gabutti G. Gabutti G. J Prev Med Hyg. 2008 Mar;49(1):47-54. J Prev Med Hyg. 2008. PMID: 18792533 Review. No abstract available.
• Use of a combined DTP-polio vaccine in a reduced schedule.

  Swartz TA, Roumiantzeff M, Peyron L, Stopler T, Drucker J, Epstein I, Leitner L, Goldblum N. Swartz TA, et al. Dev Biol Stand. 1986;65:159-66. Dev Biol Stand. 1986. PMID: 2881820